GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 70 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $213,652 | -15.8% | 124,221 | -4.5% | 0.00% | – |
| Q2 2023 | $253,603 | +8.4% | 130,053 | +128.7% | 0.00% | – |
| Q1 2022 | $234,000 | -67.3% | 56,865 | +2.1% | 0.00% | -100.0% |
| Q4 2021 | $716,000 | +27.2% | 55,695 | +6.8% | 0.00% | 0.0% |
| Q3 2021 | $563,000 | +22.7% | 52,129 | +3.8% | 0.00% | 0.0% |
| Q2 2021 | $459,000 | +33.8% | 50,229 | +38.0% | 0.00% | – |
| Q1 2021 | $343,000 | +125.7% | 36,392 | -5.5% | 0.00% | – |
| Q4 2020 | $152,000 | +83.1% | 38,492 | +22.5% | 0.00% | – |
| Q3 2020 | $83,000 | -66.0% | 31,420 | -14.7% | 0.00% | – |
| Q2 2020 | $244,000 | +38.6% | 36,816 | +21.7% | 0.00% | – |
| Q1 2020 | $176,000 | -30.7% | 30,253 | +6.9% | 0.00% | – |
| Q4 2019 | $254,000 | +5.0% | 28,303 | +0.9% | 0.00% | – |
| Q3 2019 | $242,000 | -14.2% | 28,053 | +11.0% | 0.00% | -100.0% |
| Q2 2019 | $282,000 | – | 25,279 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,450,638 | $17,536,000 | 1.82% |
| EcoR1 Capital, LLC | 3,421,287 | $13,480,000 | 0.72% |
| FRAZIER MANAGEMENT LLC | 2,061,758 | $8,123,000 | 0.63% |
| BVF INC/IL | 2,695,418 | $10,620,000 | 0.42% |
| Column Group LLC | 869,493 | $3,426,000 | 0.31% |
| Avidity Partners Management LP | 2,122,064 | $8,361,000 | 0.27% |
| Redmile Group, LLC | 3,059,794 | $12,056,000 | 0.15% |
| SkyOak Wealth, LLC | 69,778 | $275,000 | 0.09% |
| Tekla Capital Management LLC | 419,005 | $1,651,000 | 0.06% |
| Blackstone Inc. | 2,567,445 | $10,116,000 | 0.04% |